التفاصيل البيبلوغرافية
| العنوان: |
Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study. |
| المؤلفون: |
Pérez-Jacoiste Asín, María Asunción, De Castro, Marta, De Dios, Begoña, Pérez-Ayala, Ana, Lalueza, Antonio, García-Reyne, Ana, Losada, Irene, Herrero-Martínez, Juan María, Jiménez, Pilar Hernández, Lumbreras, Carlos, Lizasoain, Manuel, López Medrano, Francisco |
| المصدر: |
Pathogens & Global Health; May2024, Vol. 118 Issue 3, p232-240, 9p |
| مصطلحات موضوعية: |
MEDICAL screening, COVID-19 |
| مصطلحات جغرافية: |
MADRID (Spain) |
| مستخلص: |
Strongyloides stercoralis hyperinfection syndrome has been observed in immunosuppressed coronavirus disease 2019 (COVID-19) patients. Detecting and treating asymptomatic Strongyloides infection in individuals from endemic areas can effectively prevent hyperinfection. Unfortunately, many clinicians are unaware of this neglected infection. Therefore, we aimed to evaluate whether including Strongyloides screening in COVID-19 management protocols would encourage this practice. To accomplish this, we conducted a retrospective single-center study at 'Hospital Universitario 12 de Octubre' in Madrid, Spain, comparing two consecutive cohorts. The first cohort comprised all Latinx patients over 18 years old who were admitted for COVID-19 between March 1st and April 30th, 2020. The second cohort consisted of Latinx patients admitted between July 1st and December 31st, 2020, following an amendment to the COVID-19 management protocol that recommended screening for strongyloidiasis in at-risk patients. We identified 559 and 795 patients in the first and second periods, respectively. The percentage of individuals screened increased significantly from 8.8% to 51.6% after the screening recommendation was included in the protocol (odds ratio [OR] 11.08, 95% confidence interval [CI] 8.01–15.33). In both periods, the screening rate was significantly higher among those receiving immunosuppression than those who did not receive steroids and/or tocilizumab. No other factors influenced the screening rate. In conclusion, including strongyloidiasis screening recommendations in COVID-19 management protocols led to its increased implementation. However, the overall screening rate remained low, emphasizing the need for further efforts to enhance screening practices. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pathogens & Global Health is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher